Cellular and In Vivo Fate of DNA Nanostructures
ACS Applied Materials & Interfaces · 2026
DOI: 10.1021/acsami.6c09876 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift ACS Applied Materials & Interfaces, 2026. Verfasst von Jungang Ren und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Xiamen Medical College, Xiamen, Fujian361023, China. Hauptthemen laut MEDLINE: DNA Nanostructures, DNA, Nanostructures. Die Arbeit nennt 216 Literaturangaben. Gefördert von: Key Project of Research and Development Plan of Hunan Province, Science Fund for Distinguished Young Scholars of Hunan Province, National Natural Science Foundation of China (NSFC).
Abstract (Originalsprache)
DNA nanotechnology is a cutting-edge discipline that exploits the principle of complementary base pairing to direct the self-assembly of precisely defined nanostructures. This review systematically surveys the fundamental concepts, assembly strategies, and biomedical applications of DNA nanostructures, with a particular focus on their cellular and in vivo fate and the methodologies used to investigate these processes. We categorize representative DNA architectures by their assembly strategies into three major classes and discuss the design principles and distinctive characteristics of each. A comprehensive analysis is provided of the critical determinants governing their biological behavior, encompassing intrinsic structural parameters (size, morphology, and surface modifications) and extrinsic physiological factors (enzymatic activity, pH, and temperature). We further review the principal techniques for monitoring their cellular and in vivo dynamics—including fluorescence imaging, radiolabeling, and magnetic resonance imaging (MRI). In vivo processes—absorption, biodistribution, cellular uptake, metabolic clearance, and immunogenicity—are examined in depth. Finally, we delineate the key translational barriers and outline emerging opportunities in intelligent responsive design, immunomodulation, and theranostic integration. This review provides a conceptual framework for navigating the critical design trade-offs inherent in engineering DNA nanostructures for in vivo application and offers forward-looking perspectives for the development of DNA-based nanocarriers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Xiamen Medical College, Xiamen, Fujian361023, China.
- Department of Pharmacy, School of Pharmacy, Jiamusi University, Jiamusi, Heilongjiang154007, China.
- Department of Medicine, Brigham Women's Hospital, Harvard Medical School, Boston, Massachusetts02115, United States.
- Department of Bioengineering, University of California, Berkeley, Berkeley, California94720, United States.
- Department of Electrical Engineering and Computer Science, University of California, Berkeley, Berkeley, California94720, United States.
- Department of Pharmaceutics, Xiangya School of Pharmaceutical Sciences, Central South University, Changsha, Hunan410013, China.
ORCID-Profile: Luke P Lee, Zhenbao Liu
Förderung
- Key Project of Research and Development Plan of Hunan Province
- Science Fund for Distinguished Young Scholars of Hunan Province
- National Natural Science Foundation of China (NSFC)
- Hunan Provincial High-Level Health Talents
Zitieren
APA
Ren, J., Wu, Q., Lee, L. P., & Liu, Z. (2026). Cellular and In Vivo Fate of DNA Nanostructures. ACS Applied Materials & Interfaces. https://doi.org/10.1021/acsami.6c09876
Vancouver
Ren J, Wu Q, Lee LP, Liu Z. Cellular and In Vivo Fate of DNA Nanostructures. ACS Applied Materials & Interfaces. 2026. doi:10.1021/acsami.6c09876
BibTeX
@article{Ren2026,
author = {Ren, Jungang and Wu, Qian and Lee, Luke P and Liu, Zhenbao},
title = {Cellular and In Vivo Fate of DNA Nanostructures},
journal = {ACS Applied Materials & Interfaces},
year = {2026},
doi = {10.1021/acsami.6c09876}
}
EUVIMED